Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: A report from the Autologous Blood and Marrow Transplant Registry

Journal of Clinical Oncology

Volumn 19, Issue 2, 2001, Pages 406-413

  Vose, J M ^a   Zhang, M J ^a   Rowlings, P A ^a   Lazarus, H M ^a   Bolwell, B J ^a   Freytes, C O ^a   Pavlovsky, S ^a   Keating, A ^a   Yanes, B ^a   Van Besien, K ^a   Armitage, J O ^a   Horowitz, M M ^a   Bashey, A ^a   Bence Bruckler, I ^a   Burns, L J ^a   Fay, J W ^a   Gale, R P ^a   Gibson, J ^a   Giralt, S A ^a   Goldstein, S ^a   Herzig, R H ^a   Hiddemann, W ^a   Martino, R ^a   McCarthy, P L ^a   Miller, A ^a   Milone, G ^a   Montserrat, E ^a   Pecora, A ^a   Phillips, G L ^a   Rubin, A D ^a   Schenkein, D P ^a   Stiff, P J ^a   Vesole, D H ^a   Wingard, J R ^a   more..

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOTRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CHILD; DRUG MEGADOSE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS;

EID: 0035863505     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.2.406     Document Type: Article

References (25)

1. MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma
2. Identification of major prognostic subgroups of patients with large-cell lymphoma treated with M-BACOD or m-BACOD
3. Comparison of a standard generation combination (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma
4. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage
5. Nonparametric estimation from incomplete observations
6. Regression models and life tables
7. Effective salvage therapy for lymphoma with cisplatin in combination with high dose AraC and dexamethasone (DHAP)
8. Results of MIME salvage regimen for recurrent or refractory lymphoma
9. Effectiveness of high dose combination chemotherapy and ABMT for patients with NHL who are still responsive to conventional dose chemotherapy
10. The treatment of progressive non-Hodgkin's lymphoma with intensive chemoradiotherapy and autologous marrow transplantation
11. Bone marrow transplantation prolongs survival after relapse in aggressive lymphoma patients treated with the LNH-84 regimen
12. High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma
13. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma
14. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma
15. BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma
16. Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: Value of augmented preparative regimens - A Southwest Oncology Group trial
17. Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma
18. Intensive therapy and autotransplant for patients with an incomplete response to front-line therapy for lymphoma
19. High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: A prospective randomized Italian multicenter study
20. Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma
21. International consensus conference on high-dose therapy with hematopoietic stem-cell transplantation in aggressive non-Hodgkin's lymphomas: Report of the jury
22. Residual abdominal masses in aggressive non-Hodgkin's lymphoma after combination chemotherapy: Significance in management
23. SPECT gallium imaging versus computed tomography: Predictive value in patients undergoing high-dose chemotherapy and autologous stem cell transplantation for non-Hodgkin's lymphoma
24. Whole body positron emission tomography using fluoredeoxy glucose for staging of lymphoma: Effectiveness and comparison with computed tomography